Illness-associated productivity costs among women with employer-sponsored insurance and newly diagnosed breast cancer

J Occup Environ Med. 2010 Apr;52(4):415-20. doi: 10.1097/JOM.0b013e3181d65db7.

Abstract

Objective: Determine lost work time and job attrition for incident breast cancer (BC).

Methods: The cases were employed women, aged 18 to 64, with BC identified by a validated algorithm between 1999 and 2005, from claims (MarketScan) and attendance databases. Controls without cancer were matched 3:1 on age, comorbidity, and index year.

Results: First-year mean disability days were 60 (cases, N = 880) versus 5 (controls, N = 2640) (P < 0.001). The first-year disability costs were $4900 for cases versus $385 for controls (P < 0.001). In years 2 through 4, the disability days and associated costs were similar for the cases versus controls. After 4 years, 56.4% of cases were still enrolled in the employer-sponsored insurance programs compared to 6.5% of controls (P < 0.001).

Conclusions: The lost work associated with BC is substantial in the first year after diagnosis. Employee retention is much higher for BC cases versus controls.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / economics*
  • Breast Neoplasms / epidemiology*
  • Comorbidity
  • Cost of Illness
  • Efficiency*
  • Female
  • Humans
  • Insurance, Health, Reimbursement / economics*
  • Middle Aged
  • Young Adult